Regulatory requirements continue to evolve across global markets. Keeping pace with changes from the FDA, EMA, MHRA, PMDA, NMPA and other health authorities is critical for successful product development and lifecycle ma...

Meet ICON at #ESMO26, booth \#8005, to discuss how our scientific insight, oncology expertise, connected site network and purpose-built technology can support your program from strategy to study delivery. Explore practic...

60 colleagues. One shared cause. On 27 September, 60 members of our ICON team in Argentina joined more than 12,500 people in Buenos Aires for the 20th Caminata Avon. Together, they completed the 4.5 km walk in support ...

The countdown to #OCTNordics is on, and ICON is proud to be sponsoring this year's event in Copenhagen on 20–21 October. Drop by booth \#41 to connect with our experts and explore how ICON is driving innovation and oper...

How can sponsors generate meaningful clinical insights earlier in neurodegenerative disease development? Join ICON specialists Paula Kopschina Feltes and Matthias Mohse as they explore innovative first-in-human study des...

Diagnostics are transforming how diseases are detected, monitored and treated. At ICON, our Medical Device & Diagnostics Research team supports the development of in vitro diagnostics, companion diagnostics and emerging...

Choosing the right COA instrument should be one of the earliest decisions in clinical development. And it is one that can have long-term consequences for your trial. Should you use an existing instrument? Develop a new...

On World Heart Day, ICON is proud to highlight the importance of preventing, diagnosing and treating heart disease. Over the past five years, ICON has participated in more than 300 studies across heart failure, ischaemic...

Modern RBQM models redistribute monitoring activities across central, remote and onsite teams, helping sponsors focus oversight where it matters most. In her article for BioPharm International, Helen Yeardley examines w...

Improved research accuracy and integrity. Knowledge Manager centralized content management avoids content duplication and ensures article accuracy and data integrity. See how it could help your work. Get more information...

The pressure to make confident development decisions earlier has never been greater. Discover how innovative early phase trial designs, patient engagement strategies, and biomarker insights are helping sponsors navigate ...

As RBQM adoption grows, sponsors are rethinking how monitoring resources, data and expertise are deployed across studies. In this article for BioPharm International, Helen Yeardley explores why effective capacity planni...